Gwang-Cheol Park
Directeur Général chez Premierbio Co., Ltd.
Postes actifs de Gwang-Cheol Park
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Directeur Général | - | - |
Historique de carrière de Gwang-Cheol Park
Anciens postes connus de Gwang-Cheol Park
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DSK CO., LTD. | Directeur Général | 30/03/2016 | - |
| Président | 30/03/2016 | - | |
| HYUNDAI SECURITIES CO LTD | Directeur/Membre du Conseil | 21/06/2010 | - |
| Independent Dir/Board Member | 21/06/2010 | - |
Formation de Gwang-Cheol Park
| Konkuk University | Doctorate Degree |
Statistiques
Internationale
| Corée du Sud | 5 |
Opérationnelle
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Finance | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Bourse
- Insiders
- Gwang-Cheol Park
- Expérience
